Prescription Required
Dynaglipt 20mg Tablet contains Teneligliptin 20mg, a highly effective oral medication used to manage Type 2 diabetes mellitus (T2DM). It is part of a class of drugs known as DPP-4 inhibitors (Dipeptidyl Peptidase-4 inhibitors). Dynaglipt works by improving the body's natural ability to control blood sugar levels. It enhances insulin release in response to meals, reduces the production of excess glucose from the liver, and improves overall blood sugar control. It is typically prescribed as part of a comprehensive treatment plan that includes a balanced diet and regular exercise.
It is recommended to limit alcohol consumption while taking Dynaglipt. Alcohol can interfere with blood sugar control and may increase the risk of hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar). Always monitor your blood sugar levels closely if consuming alcohol.
Taking it during pregnancy might be unsafe. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby, consult your doctor for specific information.
It is unknown whether Dynaglipt 20mg Tablet passes into breast milk. If you are breastfeeding, consult your doctor to discuss the potential risks and benefits. Your doctor may suggest an alternative treatment.
If you have kidney problems, especially moderate to severe kidney impairment, consult your doctor before using Dynaglipt. The dose of Teneligliptin may need to be adjusted, or an alternative medication may be recommended depending on your condition.
It should be used with caution in patients with liver disease. Dose adjustment of medicine may be required. Please consult your doctor.
Teneligliptin generally does not impair your ability to drive, but it can cause dizziness or lightheadedness, especially if you have low blood sugar. Be cautious when driving or operating machinery if you experience these symptoms.
Dynaglipt 20mg Tablet contains Teneligliptin, which works by inhibiting the DPP-4 enzyme, responsible for breaking down incretin hormones. These hormones help regulate blood sugar by promoting insulin secretion when blood sugar levels rise. By blocking DPP-4, Teneligliptin increases the levels of active incretin hormones, leading to improved insulin secretion after meals and reduced glucagon levels, which helps prevent the liver from producing excess glucose. This results in better glycemic control and more stable blood sugar levels.
Type 2 diabetes is a condition where the levels of blood glucose, or blood sugar, are elevated. Glucose, derived from the foods you eat, is the primary energy source. Insulin, a hormone, facilitates the entry of glucose into cells for energy. In diabetes, the body either produces insufficient insulin or utilizes it ineffectively, leading to elevated blood glucose levels. This prolonged condition can result in health issues, but proactive diabetes management can help prevent these complications.
Store Dynaglipt 20mg Tablet in a cool, dry place, away from direct sunlight. Keep it out of reach of children and pets. Do not use the medication past its expiration date.
Dynaglipt 20mg Tablet (Teneligliptin) is an effective treatment for Type 2 diabetes mellitus. By inhibiting the DPP- 4 enzyme, it helps control blood sugar levels and reduces the risk of diabetes-related complications. It is well-tolerated and offers a convenient once-a-day dosing schedule. Always follow your healthcare provider’s advice to ensure optimal management of your diabetes.
Content Updated on
Tuesday, 11 March, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA